PF-Atlas › Methodology

How PF-Atlas Works: Methodology & Editorial Standards

Who builds PF-Atlas, where the data comes from, and how clinical fact is separated from computational modeling.

Who builds this

PF-Atlas is built and maintained by Guy Levin, an idiopathic pulmonary fibrosis patient, as an open research atlas. It is not a medical provider and does not offer medical advice. The goal is to map every IPF treatment, trial, drug and mechanism into one connected, verifiable reference.

Where the data comes from

Treatment, trial and research data are indexed from primary public sources: PubMed, ClinicalTrials.gov and the U.S. FDA, plus peer-reviewed journals and preprint servers. Each entity page links back to its source so any claim can be checked.

Three evidence levels

PF-Atlas labels everything by evidence level so readers can tell established medicine from hypothesis:

Clinically established
FDA-approved therapies and positive Phase III results.
Clinical research
Agents in human trials, Phase I through III. Promising but not yet approved.
PF-Atlas model
Computational and preclinical hypotheses from the PF-Atlas simulation engine. Not clinically validated.

Editorial standards

Pages are written by the PF-Atlas Research Team and reviewed against source data. Modeling output is always labeled as such and never presented as a treatment recommendation. Dates of last review appear on each article. Corrections can be sent through the site.

Medical disclaimer. PF-Atlas is a computational research atlas built by a patient, not a healthcare provider. Nothing here is medical advice. Always consult a qualified pulmonologist before any treatment decision.